Cooper Companies | COO - SCHULD

Aktienkurs
64.34
Täglich Wechseln
-0.08 -0.12%
Monatlich
-7.17%
Jährlich
-21.39%
Q2 Prognose
63.04




SCHULD Veränderung Datum
Abbott USD 13.86B 919M 2025-12
Align Technology USD 121.27M 1.75M 2025-09
AtriCure USD 76.73M 521K 2025-09
Avanos Medical USD 133.7M 3.6M 2025-09
Bausch Health Companies USD 21.04B 696M 2025-09
Baxter International USD 9.71B 13M 2025-09
Bayer EUR 39.39B 1.31B 2025-03
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Cooper Companies USD 2.51B 27M 2025-09
Dentsply International USD 2.48B 14M 2025-09
Dexcom USD 1.24B 1.21B 2025-12
Edwards Lifesciences USD 600M 105.4M 2026-03
Globus Medical USD 119.34M 1.76M 2025-09
Haemonetics USD 1.22B 54K 2025-09
Inogen USD 0 0 2022-06
Insulet USD 1.01B 384.9M 2025-09
Integra LifeSciences USD 2.01B 7.91M 2025-09
Intuitive Surgical USD 0 0 2025-03
J&J USD 47.93B 2.14B 2025-12
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.15M 599K 2025-09
Novartis USD 32.02B 615M 2025-09
ResMed USD 846.35M 178.06M 2025-09
STAAR Surgical USD 39.12M 1.4M 2025-09
Steris USD 2.06B 10.4M 2025-09
Stryker USD 14.86B 1.74B 2025-12
Tandem Diabetes Care USD 449.28M 276K 2025-09
Teleflex USD 2.77B 774M 2025-09
Utah Medical Products USD 0 0 2022-03
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12